Skip to content
Dendreon
  • News
  • Contact Us
  • About
  • Science and Services
    • Cellular Therapy Manufacturing
    • Provenge Immunotherapy
  • Publications
  • Careers
News Dendreon Publishes New Data In Clinical Cancer Research Correlating The Magnitude Of Cytotoxic T Cell Response To PROVENGE® (Sipuleucel-T) Treatment With Overall Survival
June 2, 2018

Dendreon Publishes New Data In Clinical Cancer Research Correlating The Magnitude Of Cytotoxic T Cell Response To PROVENGE® (Sipuleucel-T) Treatment With Overall Survival

  • News Type: Press Releases
Read More
LinkedInShareTweet
Dendreon
© Dendreon Pharmaceuticals LLC. All Rights Reserved. 2023.
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Linkedin
  • Facebook
  • Twitter